Thursday, April 29, 2021 4:07:00 PM
GEM is a Major financier for Both RLF and NRX.
Opinions.
GEM MAY not want their company's in court about RLF-100 / Zyemini.
RLF-100 + ACER + AdVita + NRX-101... Nice Pharma combo...IMO...
Aviptadil Formulation Patent is the CROWN JEWEL...
Will BRPA accept NRX not having Aviptadil Patent?
Does the QUIET suggest more May be Happening behind CLOSED DOORS? S4 share conversions?
... GLTA...
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM